Biotalys announces Chief Financial Officer succession plan
March 14 2023 - 1:00PM
Biotalys announces Chief Financial Officer succession plan
Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech)
company developing protein-based biocontrol solutions for crop and
food protection, announced today that its Board of Directors has
approved a succession plan under which Douglas Minder will be
promoted to Chief Financial Officer (CFO), effective July 1, 2023.
He will take over responsibility from Wim Ottevaere, who, after a
long and successful career in finance in the life sciences
industry, will conclude his operational role and will continue to
serve Biotalys in an advisory capacity.
“On behalf of the Board of Directors, I would
like to extend our deep appreciation to Wim for his outstanding
service to Biotalys. During his tenure, the company successfully
completed its IPO, transitioning to a publicly listed entity
preparing for commercialization,” said
Simon Moroney, Chairman of the Board. “We are
delighted to have Douglas take on the CFO role. He is a highly
knowledgeable, proven financial leader who has already demonstrated
his capabilities since joining Biotalys. We know that he will
continue to be a great asset as he steps into his new role and
joins the executive committee.”
“I warmly congratulate Douglas on his promotion.
Having already worked together for more than two years at Biotalys,
I know he is an excellent choice to become our next CFO. He has a
long, successful track record in finance and life sciences that
will serve our growth ambition,” said Patrice
Sellès, Chief Executive Officer.
“I also want to express my sincere gratitude to Wim and acknowledge
his strong leadership and dedication to Biotalys. It has been a
great pleasure to work with him, and I look forward to his
continued contribution as an advisor to the company.”
“It has been a privilege for me to work at
Biotalys and to have led its IPO in 2021, together with Patrice,
Douglas and the team,” said Wim Ottevaere, CFO. “I
am proud to have helped bring a platform-based company in the
agtech sector to the stock exchange, just like I did previously in
my career with similar technology platform companies in
pharmaceuticals. I look forward to continuing to support the
company once Douglas takes over as CFO and know I am passing the
leadership of the financial function into highly capable
hands.”
Douglas Minder joined Biotalys in January 2021
and was appointed Deputy CFO after the company’s IPO to prepare for
the role of CFO and start leading the finance team. He has over 30
years of financial experience, which includes more than eight years
at Belgium-based multinational biopharmaceutical company UCB. His
most recent position there was Finance Business Partner, where he
worked across many groups to help them align strategic objectives
with the company’s long-range financial plans. He also worked for
20 years as an auditor and consultant at Deloitte, both in Belgium
and in the U.S., where he served various Fortune 500 companies
across multiple industries, including biopharma, technology,
chemicals and manufacturing. He is an expert in U.S. GAAP and IFRS
standards and reporting requirements for both the U.S. and European
markets and has built successful cross-departmental relationships
to develop continuous improvement solutions throughout an
organization.
Douglas Minder commented: “I am
excited to take on the position of CFO and look forward to leading
the finance function and meeting with the investment community. As
we advance our pipeline programs through development and onto the
market, I will be highly focused on working with the executive
committee and Board to effectively grow the business.”
Douglas Minder
About Biotalys
Biotalys is an Agricultural Technology (AgTech)
company developing protein-based biocontrol solutions for the
protection of crops and food and aiming to provide alternatives to
conventional chemical pesticides for a more sustainable and safer
food supply. Based on its novel AGROBODY™ technology platform,
Biotalys is developing a strong and diverse pipeline of effective
product candidates with a favorable safety profile that aim to
address key crop pests and diseases across the whole value chain,
from soil to plate. Biotalys was founded in 2013 as a spin-off from
the VIB (Flanders Institute for Biotechnology) and has been listed
on Euronext Brussels since July 2021. The company is based in the
biotech cluster in Ghent, Belgium. More information can be found on
www.biotalys.com.
For further information, please
contact
Toon Musschoot, Head of IR & CommunicationT:
+32 (0)9 274 54 00E: Toon.Musschoot@biotalys.com
Important
Notice
This announcement contains statements which are
"forward-looking statements" or could be considered as such. These
forward-looking statements can be identified by the use of
forward-looking terminology, including the words ‘aim’, 'believe',
'estimate', 'anticipate', 'expect', 'intend', 'may', 'will',
'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans',
'target', 'seek', 'would' or 'should', and contain statements made
by the company regarding the intended results of its strategy. By
their nature, forward-looking statements involve risks and
uncertainties, and readers are warned that none of these
forward-looking statements offers any guarantee of future
performance. The Biotalys actual results may differ materially from
those predicted by the forward-looking statements. Biotalys makes
no undertaking whatsoever to publish updates or adjustments to
these forward-looking statements, unless required to do so by
law.
- Biotalys Persbericht CFO opvolging_14032023_NL
- Biotalys Press Release - CFO succession plan_14032023_EN
Biotalys (EU:BTLS)
Historical Stock Chart
From Oct 2024 to Oct 2024
Biotalys (EU:BTLS)
Historical Stock Chart
From Oct 2023 to Oct 2024